These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2810069)

  • 1. A comparison of parametric with semiparametric analysis of the concentration versus effect relationship of metocurine in dogs and pigs.
    Shafer SL; Varvel JR; Gronert GA
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):291-304. PubMed ID: 2810069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of sensitivity to metocurine in exercised horses.
    White DA; Hildebrand SV; Jones JH; Fung DL; Gronert GA
    Am J Vet Res; 1992 May; 53(5):757-61. PubMed ID: 1524302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise produces sensitivity to metocurine.
    Gronert GA; White DA; Shafer SL; Matteo RS
    Anesthesiology; 1989 Jun; 70(6):973-7. PubMed ID: 2729640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH
    Anesth Analg; 1980 Aug; 59(8):604-9. PubMed ID: 7190795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metocurine kinetics in patients undergoing operations requiring cardiopulmonary bypass.
    Avram MJ; Shanks CA; Henthorn TK; Ronai AK; Kinzer J; Wilkinson CJ
    Clin Pharmacol Ther; 1987 Nov; 42(5):576-81. PubMed ID: 3315392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep sedation and mechanical ventilation without paralysis for 3 weeks in normal beagles: exaggerated resistance to metocurine in gastrocnemius muscle.
    Gronert GA; Fung DL; Haskins SC; Steffey EP
    Anesthesiology; 1999 Jun; 90(6):1741-5. PubMed ID: 10360874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and neuromuscular effects of Org NC 45, pancuronium, metocurine, and d-tubocurarine in dogs.
    Booij LH; Edwards RP; Sohn YJ; Miller RD
    Anesth Analg; 1980 Jan; 59(1):26-30. PubMed ID: 7188662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of arteriovenous concentration differences on pharmacodynamic parameter estimates.
    Tuk B; Danhof M; Mandema JW
    J Pharmacokinet Biopharm; 1997 Feb; 25(1):39-62. PubMed ID: 9353693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose requirement of d-tubocurarine and metocurine used for chronic respiratory paralysis in neonates.
    Nussmeier N; Henry GW; Stevens DC; Schreiner RL; Grosfeld JL
    J Pediatr Surg; 1981 Oct; 16(5):700-3. PubMed ID: 7310604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH; deBros FM
    Anesth Analg; 1981 Jan; 60(1):12-7. PubMed ID: 7192943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allometry of pharmacokinetics and pharmacodynamics of the muscle relaxant metocurine in mammals.
    Gronert GA; Fung DL; Jones JH; Shafer SL; Hildebrand SV; Disbrow EA
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R85-91. PubMed ID: 7840343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuromuscular blocking effect of trimetaphan alone and in combination with different non-depolarizing muscle relaxants in the rat.
    Pollard BJ; van der Spek AF
    J Pharm Pharmacol; 1987 Nov; 39(11):896-9. PubMed ID: 2892913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative examination of the interaction of competitive neuromuscular blocking agents on the indirectly elicited muscle twitch.
    Waud BE; Waud DR
    Anesthesiology; 1984 Oct; 61(4):420-7. PubMed ID: 6486503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metocurine pharmacokinetics and pharmacodynamics in goats.
    Antognini JF; Wood R; Gronert GA
    J Vet Pharmacol Ther; 1995 Dec; 18(6):464-7. PubMed ID: 8789701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of vecuronium, atracurium, pancuronium, metocurine and RGH-4201 in dogs.
    Hackett GH; Jantzen JP; Earnshaw G
    Acta Anaesthesiol Scand; 1989 May; 33(4):298-303. PubMed ID: 2566252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative haemodynamic effects of tubocurarine and metocurine in the dog.
    Antonio RP; Philbin DM; Savarese JJ
    Br J Anaesth; 1979 Nov; 51(11):1007-10. PubMed ID: 518800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dose response effect of long-acting nondepolarizing neuromuscular blocking agents in children.
    Goudsouzian NG; Martyn JJ; Liu LM; Ali HH
    Can Anaesth Soc J; 1984 May; 31(3 Pt 1):246-50. PubMed ID: 6722619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of neuromuscular blockade. I. Relationship between twitch depression and stimulation frequency after d-tubocurarine administration.
    Tajima T; Kaneko K; Hatanaka T; Aiba T; Katayama K; Koizumi T
    Biol Pharm Bull; 1994 Aug; 17(8):1083-8. PubMed ID: 7820113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rocuronium pharmacodynamic models for published five pharmacokinetic models: age and sex are covariates in pharmacodynamic models.
    Masui K; Ishigaki S; Tomita A; Otake H
    J Anesth; 2018 Oct; 32(5):709-716. PubMed ID: 30099599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metocurine in infants and children: neuromuscular and clinical effects.
    Goudsouzian NG; Liu LM; Savarese JJ
    Anesthesiology; 1978 Oct; 49(4):266-9. PubMed ID: 697081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.